On Monday, the Food and Drug Administration (FDA) approved its first take-home coronavirus test through an emergency use authorization (EUA).
The EUA was given to the Laboratory Corporation of America (LabCorp) for its COVID-19 RT-PCR Test, which uses a sample collected from the patient’s nose via a designated self-collection kit containing nasal swabs and saline.
After patients self-swab, they will mail their sample in an insulated package to a LabCorp lab for testing.
“Our at-home collection kits are designed to make it easier and safer to test healthcare workers and first responders during this important time,” said president and CEO of LabCorp, Adam Schechter, in an online statement.
On the LabCorp website, the kit is listed as a COVID-19 Test (At-Home Kit) and retails for $119. Those interested in purchasing a kit will need to complete a short eligibility survey before placing their order.
LabCorp intends to make the Pixel by LabCorp home collection kits available to consumers in most states, with a doctor’s order, in the coming weeks.
— U.S. FDA (@US_FDA) April 21, 2020